Close Menu

mergers & acquisitions

The all-stock merger will combine the scientific informatics firms, with Accelrys CEO Max Carnecchia leading the merged entity.

The animal and food safety company Neogen bought the agricultural trait selection business to enhance its genomics-based diagnostics products.

Through the transaction, MDRNA will gain Cequent's orally delivered transkingdom RNAi technology, which involves using attenuated Escherichia coli to transcribe therapeutic shRNAs.

Luminex's acquisition of BSD Robotics will provide it with new technologies in automation and robotics in the field of dry sample handling.

Genetix will operate as a separate business unit within Danaher subsidiary Leica Microsystems.

The sale of the product lines to Bruker will clear the way for Agilent to complete its $1.5 billion acquisition of Varian, which is now expected by the end of April.

Thermo completed the acquisition of the Finland-based maker of reagents, consumables, kits, and instruments for molecular biology applications.

The $7.2 billion deal would create a life sciences tools and pharmaceutical firm with annual revenues of nearly $3 billion.

PerkinElmer has purchased the ICP-MS joint venture from Danaher that was at the center of PerkinElmer's earlier legal action against MDS.

Two days after reports that Thermo Fisher Scientific had made a $6 billion bid for the firm, Millipore confirmed it is evaluating strategic alternatives.


ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.